AI analysis of one-year CT changes predicts disease progression and survival in fibrotic interstitial lung disease.
Key Details
- 1Researchers at National Jewish Health used an AI-based tool to detect subtle increases in lung fibrosis on serial CT scans.
- 2A 5% or more increase in fibrosis score over one year doubled the risk of death or lung transplant for patients.
- 3AI-derived fibrosis changes predicted steeper lung function decline, especially in patients with less severe baseline disease.
- 4The deep learning method, data-driven textural analysis (DTA), provided precise, objective fibrosis quantification.
- 5Results were validated with data from the Pulmonary Fibrosis Foundation Patient Registry, demonstrating generalizability.
- 6Quantitative CT analysis could be used for trial endpoints and real-world risk stratification.
Why It Matters
This study demonstrates the clinical potential of deep learning-based CT quantification for early risk identification and outcome prediction in fibrotic lung disease. It supports wider use of imaging AI as an objective, reproducible tool for prognosis and treatment decision-making in complex pulmonary disorders.
Source
EurekAlert
Related News
•EurekAlert
Imaging Reveals Skull Changes and Immune Impact in Glioblastoma
Advanced imaging uncovers that glioblastoma affects the skull and immune system, not just the brain.
•EurekAlert
AI Time Series Model Boosts EEG-Based Seizure Prediction by 44%
UC Santa Cruz engineers' 'future-guided' deep learning improves seizure prediction accuracy using EEG data.
•EurekAlert
NTU Singapore to Launch Master's in AI in Medicine for Clinicians and Technologists
NTU Singapore will launch a new MSc in Artificial Intelligence in Medicine to train clinicians and technologists in clinical AI applications from 2026.